Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 4

Ecallantide is a novel treatment for attacks of hereditary angioedema due to C1 inhibitor deficiency

Total article views   HTML views PDF downloads Totals
17,648 Dovepress* 12,901+ 2,254 15,155
PubMed Central* 4,747 704 5,451
Totals 17,648 2,958 20,606
*Since 31 May 2011
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 2 6

View citations on PubMed Central and Google Scholar